Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -430,563 | -250,616 | -447,508 | 235,239 | 76,190 |
| Depreciation Amortization | 34,357 | 17,040 | 8,066 | -2,553 | -6,205 |
| Accounts receivable | 206,249 | 74,693 | -57,383 | -201,661 | -34,197 |
| Other Working Capital | -261,471 | -232,243 | -281,777 | -716,606 | -591,612 |
| Other Operating Activity | 114,743 | 69,026 | 195,165 | 479,794 | 257,991 |
| Operating Cash Flow | $-336,685 | $-322,100 | $-583,437 | $-205,787 | $-297,833 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 151,277 | 64,726 | -3,900 | N/A | 100,317 |
| PPE Investments | -98,381 | -75,447 | -43,651 | -136,956 | -98,874 |
| Purchase Of Investment | -245,819 | -245,819 | -241,388 | -1,099,595 | N/A |
| Sale Of Investment | 174,095 | N/A | N/A | 2,002,112 | N/A |
| Purchase Sale Intangibles | -7,738 | -2,426 | -2,238 | -10,000 | -10,000 |
| Other Investing Activity | -7,738 | -2,426 | -2,238 | -10,000 | -10,000 |
| Investing Cash Flow | $-26,566 | $-258,966 | $-291,177 | $755,561 | $-8,557 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -127,455 | -3,514 | -3,210 | -68 | N/A |
| Common Stock Issued | 36,119 | 17,181 | 15,681 | 79,525 | 75,815 |
| Common Stock Repurchased | -25,013 | -25,013 | N/A | N/A | N/A |
| Other Financing Activity | -12,787 | 0 | 0 | 45,349 | 0 |
| Financing Cash Flow | $-129,136 | $-11,346 | $12,471 | $124,806 | $75,815 |
| Beginning Cash Position | 1,118,589 | 1,118,589 | 1,118,589 | 444,009 | 444,009 |
| End Cash Position | 626,202 | 526,177 | 256,446 | 1,118,589 | 213,434 |
| Net Cash Flow | $-492,387 | $-592,412 | $-862,143 | $674,580 | $-230,575 |
| Free Cash Flow | |||||
| Operating Cash Flow | -336,685 | -322,100 | -583,437 | -205,787 | -297,833 |
| Capital Expenditure | -98,381 | -75,447 | -43,651 | -136,956 | -98,874 |
| Free Cash Flow | -435,066 | -397,547 | -627,088 | -342,743 | -396,707 |